• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


Rodeina Challand (Executive Director, #Biosimilar Development) will be presenting "Challenges in Demonstrating...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences, Inc. Announces Pricing of its Initial Public Offering

12 November 2014, Raleigh, N.C. – PRA Health Sciences, Inc. (“PRA”), a leading global contract research organization, today announced the pricing of its initial public offering of...

PRA Health Sciences Files for Initial Public Offering

08 September 2014, Raleigh, N.C. PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC)...

PRA Health Sciences Expands in Pennsylvania

26 August 2014, Blue Bell, PA – Blue Bell, Pennsylvania will soon be home to PRA Health Sciences’ largest office worldwide. PRA, a leading global Contract Research Organization (CRO), is...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

FACT SHEET: Oncology & Hematology
November 17, 2014

During the last 5 years, PRA has participated in more than 400 oncology and hematology clinical projects globally

FACT SHEET: Infectious Diseases
November 17, 2014

Our infectious diseases experts pioneered the innovative evidence-based methodology used at PRA to ensure successful start-up and conduct of our clients’ global studies

Whitpaper - Global Biosimilar Development
October 28, 2014

Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy.


Find out what's happening next on PRA's event schedule

November 25 - November 28

Oncology Asia is the first strategy conference that focuses on the development and effective market access of cancer drugs in the region. This is the meeting to learn how to expedite oncology clinical development and break through established and emerging markets in Asia.

November 26 - November 27

Celebrating its 10th anniversary, this prestigious conference offers its participants both an overview of the most relevant pharmacovigilance (PV) issues and a unique insight into the experiences of leading industry experts. This extraordinary opportunity will provide a platform to compare experiences, share best practice and anticipate the future of PV legislation in a changing European […]

December 6 - December 9

The American Society of Hematology (ASH) invites you to save the date for the 56th ASH Annual Meeting in San Francisco, CA. As the premier event in malignant and non-malignant hematology, this meeting will provide attendees with an invaluable educational experience and the opportunity to: – Review more than 3,000 scientific abstracts highlighting the updates […]

Read More >